ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.480,89
0,21%
S&P 500
5.187,67
0,00%
US Dollar vs BRL
5,0891
-0,01%
Bitcoin
61.276,36
0,15%
Brent Oil
83,625
0,08%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Intersect ENT Inc (XENT)

  7. Intersect ENT Inc (XENT) Notícias

XENT

Intersect ENT (XENT)

Intersect ENT Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:XENT
DataHoraFonteTítuloCódigoCompanhia
10/02/202318:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XENTIntersect ENT Inc
12/09/202214:11Edgar (US Regulatory)Withdrawal of a Registration Statement Withdrawal Request (rw Wd)NASDAQ:XENTIntersect ENT Inc
19/05/202217:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:XENTIntersect ENT Inc
18/05/202207:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XENTIntersect ENT Inc
16/05/202219:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XENTIntersect ENT Inc
13/05/202210:08Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:XENTIntersect ENT Inc
13/05/202210:01Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:XENTIntersect ENT Inc
13/05/202209:59Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:XENTIntersect ENT Inc
09/05/202218:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XENTIntersect ENT Inc
04/05/202217:43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XENTIntersect ENT Inc
29/04/202217:04Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:XENTIntersect ENT Inc
08/03/202218:14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XENTIntersect ENT Inc
08/03/202218:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XENTIntersect ENT Inc
31/01/202216:35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XENTIntersect ENT Inc
25/01/202209:00Business WireReal-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource UtilizationNASDAQ:XENTIntersect ENT Inc
02/11/202117:15Business WireIntersect ENT Reports Third Quarter 2021 Financial ResultsNASDAQ:XENTIntersect ENT Inc
28/10/202108:00Business WireFirst Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in EuropeNASDAQ:XENTIntersect ENT Inc
30/09/202117:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XENTIntersect ENT Inc
19/08/202109:47Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XENTIntersect ENT Inc
09/08/202115:47PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc.NASDAQ:XENTIntersect ENT Inc
09/08/202112:07TipRanksMedtronic Gains Investor Confidence with Intersect BuyoutNASDAQ:XENTIntersect ENT Inc
09/08/202106:55TipRanksIntersect ENT’s Q2 Results Miss Expectations; Shares Jump on Acquisition NewsNASDAQ:XENTIntersect ENT Inc
06/08/202111:24Dow Jones NewsIntersect ENT Shares Rise on Medtronic Takeover DealNASDAQ:XENTIntersect ENT Inc
06/08/202108:48Dow Jones NewsMedtronic to Buy Intersect ENT for $28.25/ShareNASDAQ:XENTIntersect ENT Inc
06/08/202108:15Business WireIntersect ENT Reports Second Quarter 2021 Financial ResultsNASDAQ:XENTIntersect ENT Inc
06/08/202108:00PR Newswire (US)Medtronic to Acquire Intersect ENTNASDAQ:XENTIntersect ENT Inc
26/07/202108:00Business WireU.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic RhinosinusitisNASDAQ:XENTIntersect ENT Inc
23/07/202109:00Business WireIntersect ENT to Report Second Quarter 2021 Financial Results on August 6NASDAQ:XENTIntersect ENT Inc
22/07/202117:05Business WireIntersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term LoanNASDAQ:XENTIntersect ENT Inc
20/05/202108:46Business WireIntersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus...NASDAQ:XENTIntersect ENT Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:XENT

Seu Histórico Recente

BOV
COGN3
COGNA ON
BOV
JHSF3
JHSF PART ON
BOV
OIBR3
OI ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IBOV
Índice Bovespa
BOV
IFCM3
Infracommerce Caxaas ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados